Analysis of Clinical Predictive Factors Affecting the Outcome of 2nd Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer.
Conclusions: : SL may be beneficial for patients without peritonealmetastasis or thrombotic events who have a single metastasis and a level of CA19-9 less than 90 U/mL.This prognostic nomogram can be used to predict mOS before the administration of SL after the failureof gemcitabine-based FL.
PMID: 30974927 [PubMed - as supplied by publisher]
Source: Gut and Liver - Category: Gastroenterology Tags: Gut Liver Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastroenterology | Liver | Pancreas | Pancreatic Cancer | Thrombosis | Urology & Nephrology